The goal of this work is to examine the role of the CCK-BR molecular and protein signaling pathways in activated pancreatic stellate cells and determine how interruption of this pathway can decrease the cancer-PSC cross communication and growth of pancreatic cancer. This evidence concerns the gene CCK and familial pancreatic carcinoma.